Recent Updates
Recently added Catalysts
VTRS Positive Sentiment Score: 60/100

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025 Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 ...

Key Takeaway: Viatris Inc. (NASDAQ: VTRS) is set to report its financial results for the first quarter of 2025 on May 8, 2025. The announcement includes a webcast hosted by company executives at 8:30 a.m. ET for both investors and the public. This webcast will offer an opportunity to discuss the company's performance and strategic initiatives. Viatris is known for its role in bridging generics and branded medications effectively, serving approximately 1 billion patients globally each year.

Market Sentiment Analysis

POSITIVE FACTORS

  • Viatris will provide financial updates that are critical for investors.
  • The company continues to emphasize its mission to improve global healthcare access.
  • A wide audience can engage with the company's performance through a live webcast.

Full Press Release Details

PITTSBURGH , March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS ) will report first quarter 2025 financial results on Thursday, May 8, 2025 . Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.
Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.
About Viatris Viatris Inc. (NASDAQ: VTRS ) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh , Shanghai and Hyderabad, India . Learn more at viatris.com and investor.viatris.com , and connect with us on LinkedIn , Instagram , YouTube and X (formerly Twitter).
SOURCE Viatris Inc.

21 %

About Viatris Inc.

Ticker Symbol: VTRS
Exchange: NASDAQ
Mission: Empower people worldwide to live healthier at every stage of life
Patient Reach: ~1 billion patients annually
Global Centers: Pittsburgh, Shanghai, Hyderabad

Frequently Asked Questions

When will Viatris report its Q1 2025 financial results?

Viatris will report its Q1 2025 financial results on May 8, 2025.

How can I join the Viatris financial webcast?

You can join the webcast at investor.viatris.com or call 844.308.3344.

What is Viatris's mission?

Viatris aims to empower people to live healthier at every stage of life.

Where is Viatris headquartered?

Viatris is headquartered in the U.S. with global centers in Pittsburgh, Shanghai, and Hyderabad.

How many patients does Viatris supply medicines to annually?

Viatris supplies high-quality medicines to approximately 1 billion patients each year.

Last updated: Mar 28, 2025